Search
Chemeq founder Graham Melrose.

Chemeq founder plans $5m IPO

A Bentley biotech company led by Graham Melrose is planning a $5 million initial public offering, after six years of research on the development of synthetic antibiotics.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Recce (RCE)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/06/18

1 year TSR5 year TSR
144thUltima United90%5%
516thRecce-7%0%
597thUltracharge-18%2%
798thPLC Financial Solutions-68%10%
722 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/03/17
$20k Sold
16/01/17
$0 Bought
16/01/17
$0 Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

180th↓Recce$139k
202nd-Kabuni$10k
204th-PLC Financial Solutions$6k
206th↓Ultracharge$3k
207th↓Ultima United$2k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer